19 results
P
I/C
l, o, w, -, l, e, v, e, l, , a, r, s, e, n, i, c, , (, A, s, ), , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r, d, r, i, n, k, i, n, g, , w, a, t, e, r, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, s, , l, o, w, e, r, , t, h, a, n, , t, h, e, , W, H, O, , p, r, o, v, i, s, i, o, n, a, l, , g, u, i, d, e, l, i, n, e, , v, a, l, u, e, , (, 1, 0, , µ, g, /, L, )
O
p, o, o, l, e, d, , a, s, s, o, c, i, a, t, i, o, n, , b, e, t, w, e, e, n, , t, h, e, , r, e, l, a, t, i, v, e, , r, i, s, k, , o, f, , e, a, c, h, , c, a, r, d, i, o, v, a, s, c, u, l, a, r, , d, i, s, e, a, s, e, , (, C, V, D, ), , e, n, d, p, o, i, n, t, , a, n, d, , l, o, w, -, l, e, v, e, l, , A, s, , c, o, n, c, e, n, t, r, a, t, i, o, n, , i, n, , d, r, i, n, k, i, n, g, , w, a, t, e, r
P
patients with localized infections
I/C
antibiotics formulated at concentrations between 0 and 6% w/w into bone cements, gentamycin-infused bone cement mixtures
O
eradication or delay of infection onset
P
poststroke motor dysfunction
I/C
rehabilitation techniques, different traditional Chinese and western medicine rehabilitation techniques
O
improvement of the total scores of Fugl-Meyer Assessment, Action Research Arm Test, and Berg Balance Scale
P
stroke patients
I/C
Buyang Huanwu decoction (BYHWD), conventional treatment alone
O
clinical effective rate (CER), National Institutes of Health Stroke Scale (NIHSS) score, Fugl-Meyer Assessment (FMA) score
P
experimental mammals
I/C
radiofrequency electromagnetic field (RF-EMF) exposure, no exposure
O
fecundity, offspring health at birth, delayed effects
P
rowers
I/C
caffeine ingestion, placebo
O
performance on a rowing ergometer
P
Japanese quails
I/C
meta-analysis of studies conducted in different countries, studies conducted in Brazil vs. studies conducted in other countries
O
growth potential of Japanese quails, Gompertz growth parameters (Wm, Wi, B, IP)
P
type 2 diabetes patients
I/C
E-health interventions, SMS-based intervention, smartphone applications, phone calls, short message service, websites, wearable devices, usual care
O
glycemic control, HbA1c levels
P
Benzophenone-3 (BP-3), Benzophenone-1 (BP-1)
I/C
Sunscreens and cosmetics, Inorganic UV filters
O
Endocrine disrupting properties
P
Orthodontic-surgical treatment patients
I/C
Conventional combined orthodontic-surgical treatment, No treatment or alternative treatments
O
Oral health-related quality of life